At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VERX Vertex, Inc.
Closed 03-13 16:00:00 EDT
13.30
-0.44
-3.20%
盘后13.30
+0.000.00%
19:37 EDT
High13.89Low13.18Vol2.05M
Open13.73D1 Closing13.74Amplitude5.17%
Mkt Cap2.12BTradable Cap932.52MTotal Shares159.53M
T/O27.35MT/O Rate2.92%Tradable Shares70.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Dow Jones  ·  04:37
Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
GlobeNewswire  ·  03-13 04:15
Vertex Achieves Remarkable Growth, Sets New Industry Standard with ServiceTitan
Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
Dow Jones  ·  03-12 04:37
Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
Vertex Pharmaceuticals Is Maintained at Buy by Truist Securities
Dow Jones  ·  03-11 23:22
Vertex Pharmaceuticals Is Maintained at Buy by Truist Securities
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
TIPRANKS  ·  03-11 20:17
Vertex Pharmaceuticals price target raised to $525 from $490 at Truist
Canaccord Genuity Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)
TIPRANKS  ·  03-11 18:57
Canaccord Genuity Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)
Vertex Minerals Plans New 7 Million-Option Issue for Future Funding Flexibility
TIPRANKS  ·  03-11
Vertex Minerals Plans New 7 Million-Option Issue for Future Funding Flexibility
Vertex Minerals Reshapes Debt With A$4.5m Loan Package to Fund Reward Gold Mine
TIPRANKS  ·  03-11
Vertex Minerals Reshapes Debt With A$4.5m Loan Package to Fund Reward Gold Mine
Here’s Why Vertex Pharmaceuticals Stock (VRTX) Is Up 10% Today
TIPRANKS  ·  03-10
Here’s Why Vertex Pharmaceuticals Stock (VRTX) Is Up 10% Today
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Benzinga_recent_news  ·  03-10
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Vertex Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk
Dow Jones  ·  03-10
Vertex Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)
TIPRANKS  ·  03-10
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Design Therapeutics (DSGN) and Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones  ·  03-10
Vertex Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Vertex Pharmaceuticals: RAINIER Data Strengthen Best-in-Class IgAN Potential and Support Upside Beyond Durable CF Cash Flows
TIPRANKS  ·  03-10
Vertex Pharmaceuticals: RAINIER Data Strengthen Best-in-Class IgAN Potential and Support Upside Beyond Durable CF Cash Flows
Scotiabank Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
TIPRANKS  ·  03-10
Scotiabank Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals price target raised to $585 from $575 at Citi
TIPRANKS  ·  03-10
Vertex Pharmaceuticals price target raised to $585 from $575 at Citi
Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $596 From $570, Maintains Overweight Rating
MT Newswires Live  ·  03-10
Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $596 From $570, Maintains Overweight Rating
Vertex Stock Jumps. What Wall Street Is Saying About Its Kidney Drug Trial. -- Barrons.com
Dow Jones  ·  03-10
Vertex Stock Jumps. What Wall Street Is Saying About Its Kidney Drug Trial. -- Barrons.com
Vertex Pharmaceuticals: Upgraded Confidence in Povetacicept Drives Strengthened Buy Thesis After Robust Phase III RAINIER Data in IgA Nephropathy
TIPRANKS  ·  03-10
Vertex Pharmaceuticals: Upgraded Confidence in Povetacicept Drives Strengthened Buy Thesis After Robust Phase III RAINIER Data in IgA Nephropathy
Vertex Raises FY Dividend Plan to Y35.00
Dow Jones  ·  03-10
Vertex Raises FY Dividend Plan to Y35.00

Introduction

Company Name.
Vertex, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Vertex, Inc. provides tax technology solutions for retail, communication, leasing, retail trade, wholesale trade, technology, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, analytics and insights, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also provides implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. Vertex, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Issue price:
--